SEC 13F Intelligence

Decheng Capital Management III (Cayman), LLC / AURA

Decheng Capital Management III (Cayman), LLC’s Aura Biosciences Inc Position

Does Decheng Capital Management III (Cayman), LLC own Aura Biosciences Inc (AURA)? Yes — 1.16M shares worth $18M (+6.09% of its 13F portfolio) as of Q4 2023.

Position Value
$18M
Q4 2023
Shares
1.16M
% of Portfolio
+6.09%
Quarters Held
8
currently held

Position History AURA

Reported value by quarter
Q1 ’22: $5MQ1 ’22Q2 ’22: $3MQ2 ’22Q3 ’22: $4MQ3 ’22Q4 ’22: $3MQ4 ’22Q1 ’23: $3MQ1 ’23Q2 ’23: $4MQ2 ’23Q3 ’23: $18MQ3 ’23Q4 ’23: $18MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20231.16M$18M+6.09%
Q3 20231.16M$18M+5.83%
Q2 2023293.3K$4M+1.14%
Q1 2023293.3K$3M+1.10%
Q4 2022293.3K$3M+1.15%
Q3 2022210.0K$4M+1.38%
Q2 2022210.0K$3M+1.13%
Q1 2022210.0K$5M+1.42%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Decheng Capital Management III (Cayman), LLC’s full portfolio or all institutional holders of AURA.